[go: up one dir, main page]

CU20140126A7 - MANUFACTURING PROCEDURE FOR A PHARMACEUTICAL DOSAGE FORM INCLUDING NIFEDIPINE AND CANDESARTÁN CILEXETILO - Google Patents

MANUFACTURING PROCEDURE FOR A PHARMACEUTICAL DOSAGE FORM INCLUDING NIFEDIPINE AND CANDESARTÁN CILEXETILO

Info

Publication number
CU20140126A7
CU20140126A7 CU2014000126A CU20140126A CU20140126A7 CU 20140126 A7 CU20140126 A7 CU 20140126A7 CU 2014000126 A CU2014000126 A CU 2014000126A CU 20140126 A CU20140126 A CU 20140126A CU 20140126 A7 CU20140126 A7 CU 20140126A7
Authority
CU
Cuba
Prior art keywords
pharmaceutical dosage
dosage form
cilexetilo
candesartán
manufacturing procedure
Prior art date
Application number
CU2014000126A
Other languages
Spanish (es)
Inventor
Adrian Funke
Günter Meller
Martina Smikalla
Andreas Meeners
Markus Wirges
Jochen Axel Zeitler
Daniela Brock
Sarah Just
Peter Kleinebudde
Klaus Knop
Rolf-Anton Boeggering
Original Assignee
Bayer Fharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2013/059110 external-priority patent/WO2013167453A1/en
Application filed by Bayer Fharma Ag filed Critical Bayer Fharma Ag
Publication of CU20140126A7 publication Critical patent/CU20140126A7/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a procedimientos de fabricación para la preparación de una forma de dosificación farmacéutica que comprende nifedipina y candesartán cilexetilo y, opcionalmente, al menos un diurético, caracterizada por que la nifedipina se libera en el organismo de una manera controlada (modificada) y el candesartán cilexetilo se libera rápidamente (liberación inmediata [LI]) y, opcionalmente, el diurético se libera rápidamente (liberación inmediata [LI]), y a las formas de dosificación farmacéuticas que se pueden obtener mediante dichos procedimientos.The present invention relates to manufacturing processes for the preparation of a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil and, optionally, at least one diuretic, characterized in that nifedipine is released in the body in a controlled (modified) manner. and candesartan cilexetil is rapidly released (immediate release [LI]) and, optionally, the diuretic is rapidly released (immediate release [LI]), and to the pharmaceutical dosage forms that can be obtained by such procedures.

CU2014000126A 2013-01-18 2014-11-03 MANUFACTURING PROCEDURE FOR A PHARMACEUTICAL DOSAGE FORM INCLUDING NIFEDIPINE AND CANDESARTÁN CILEXETILO CU20140126A7 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13151946 2013-01-18
PCT/EP2013/059110 WO2013167453A1 (en) 2012-05-07 2013-05-02 Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil

Publications (1)

Publication Number Publication Date
CU20140126A7 true CU20140126A7 (en) 2015-03-30

Family

ID=47603379

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2014000126A CU20140126A7 (en) 2013-01-18 2014-11-03 MANUFACTURING PROCEDURE FOR A PHARMACEUTICAL DOSAGE FORM INCLUDING NIFEDIPINE AND CANDESARTÁN CILEXETILO

Country Status (1)

Country Link
CU (1) CU20140126A7 (en)

Similar Documents

Publication Publication Date Title
CR20140511A (en) MANUFACTURING PROCEDURE FOR A PHARMACEUTICAL DOSAGE FORM INCLUDING NIFEDIPINE AND CANDESARTÁN CILEXETILO
UY32260A (en) PHARMACEUTICAL DOSAGE FORM INCLUDING NIFEDIPINO OR NISOLDIPINO AND AN ANTAGONIST OF ANGIOTENSIN II AND / OR DIURETIC
ECSP21072161A (en) LINACLOTIDE DELAYED RELEASE COMPOSITIONS
SV2018005610A (en) SUBSTITUTED OXOPIRIDINE DERIVATIVES
UY34306A (en) SUBSTITUTED CONDENSED PYRIMIDINS AND THEIR USE
CL2015002164A1 (en) Combined formulation of two antiviral compounds.
UY35916A (en) TRICYCLIC COMPOUNDS AS BROMODOMINUM INHIBITING ANTINEOPLASTIC AGENTS
DOP2014000255A (en) BICYCLICALLY REPLACED URACILES AND USE OF THE SAME
PT3003285T (en) Solid pharmaceutical dosage form for release of at least one active pharmaceutical ingredient in the oral cavity
MX2016013236A (en) Immunosuppressant formulation.
ES2524385R1 (en) Pharmaceutical composition and its use to prepare a medicine for the treatment and prevention of HIV diseases
HUE050913T2 (en) Treatment procedure to improve the condition of the eye with a sustained release drug implant
BR112015029894A2 (en) solid pharmaceutical dosage form
CL2016000787A1 (en) Pharmaceutical composition in the form of a tablet comprising atazanavir and cobicistat; preparation procedure; and use of the composition to prepare a medicament useful for treating human immunodeficiency virus (hiv) infection.
MX2016000037A (en) Inhibitors of viral replication, their process of preparation and their therapeutical uses.
CO7111317A2 (en) Method for the treatment of gynecological diseases
CU20140126A7 (en) MANUFACTURING PROCEDURE FOR A PHARMACEUTICAL DOSAGE FORM INCLUDING NIFEDIPINE AND CANDESARTÁN CILEXETILO
PE20170201A1 (en) PHARMACEUTICAL DOSAGE FORMS
EP2799043A4 (en) Vaginal ring including meloxicam and an agent for modulating the release of the active principle, which can be used as a continuous-use contraceptive in women
DOP2015000290A (en) BENZOXAZOLES REPLACED
CO2018007821A2 (en) Pharmaceutical Combination Formulation
TH1401006699A (en) A process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan xylacetyl.
ITAN20130019A1 (en) FAZZOLETTO ACTING TO STOP THE DROP OF THE NOSE DUE TO A COLD OR ALLERGIC FORMS.
IN2013MU03855A (en)